Month: November 2018

Type 1 diabetes (T1D) used to be known as juvenile diabetes because it is often first diagnosed during childhood. Since the pancreas produces little to no insulin, difficulty regulating blood […]

New and innovative research is essential to continuing to expand scientific knowledge and improve the future of healthcare. Yet over the years, the biomedical community has seen a troubling downward […]

For individuals with type 1 diabetes (T1D), insulin is a life-saver. Literally. Without it, their body can go into a state of diabetic ketoacidosis where blood sugar becomes so high […]

A common strategy used by researchers in treating type 1 diabetes (T1D) is to destroy or deactivate immune cells that mistakenly attack insulin-producing beta cells. There have been many variations […]